Thymosin beta 4 enhances NK cell cytotoxicity mediated by ICAM-1

Immunology Letters

Volumn 123, Issue 1, 2009, Pages 72-76

  Lee, Ha reum ^a   Yoon, Sun Young ^a   Kang, Ho Bum ^a   Park, Sunyoung ^a   Kim, Kyung Eun ^a   Cho, Young Hoon ^b   Kim, Seonghan ^c   Kim, Chul woo ^c   Cho, Byung Joo ^d   Lee, Wang Jae ^c   Bang, Sa Ik ^e   Park, Hyunjeong ^f   Cho, Daeho ^a  

^a Sookmyung Women's University   (South Korea)

^b Namyang Dairy Co Ltd   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

^d Konkuk University School of Medicine   (South Korea)

^e Sungkyunkwan University School of Medicine   (South Korea)

^f The Catholic University of Korea   (South Korea)

Author keywords

ICAM 1; NK cell cytotoxicity; Thymosin beta 4

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; THYMOSIN BETA4;

ARTICLE; CYTOLYSIS; CYTOTOXICITY; HUMAN; HUMAN CELL; IMMUNITY; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; EXOCYTOSIS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; KILLER CELLS, NATURAL; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; PEPTIDES; THYMOSIN; UP-REGULATION;

EID: 64149105500     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2009.02.008     Document Type: Article

References (51)

1. Goldstein A.L., Slater F.D., and White A. Preparation assay, and partial purification of a thymic lymphocytopoietic factor (thymosin). Proc Natl Acad Sci USA 56 (1966) 1010-1017
2. Low T.L., and Goldstein A.L. Chemical characterization of thymosin beta 4. J Biol Chem 257 (1982) 1000-1006
3. Huff T., Muller C.S., Otto A.M., Netzker R., and Hannappel E. Beta-Thymosins, small acidic peptides with multiple functions. Int J Biochem Cell Biol 33 (2001) 205-220
4. Hannappel E., and Huff T. The thymosins. Prothymosin alpha, parathymosin, and beta-thymosins: structure and function. Vitam Horm 66 (2003) 257-296
5. Safer D., Elzinga M., and Nachmias V.T. Thymosin beta 4 and Fx, an actin-sequestering peptide, are indistinguishable. J Biol Chem 266 (1991) 4029-4032
6. Hannappel E. Beta-Thymosins. Ann N Y Acad Sci 1112 (2007) 21-37
7. Sun H.Q., and Yin H.L. The beta-thymosin enigma. Ann N Y Acad Sci 1112 (2007) 45-55
8. Bednarek R., Boncela J., Smolarczyk K., Cierniewska-Cieslak A., Wyroba E., and Cierniewski C.S. Ku80 as a novel receptor for thymosin beta4 that mediates its intracellular activity different from G-actin sequestering. J Biol Chem 283 (2008) 1534-1544
9. Malinda K.M., Goldstein A.L., and Kleinman H.K. Thymosin beta 4 stimulates directional migration of human umbilical vein endothelial cells. Faseb J 11 (1997) 474-481
10. Smart N., Risebro C.A., Melville A.A., Moses K., Schwartz R.J., Chien K.R., et al. Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization. Nature 445 (2007) 177-182
11. Malinda K.M., Sidhu G.S., Mani H., Banaudha K., Maheshwari R.K., Goldstein A.L., et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol 113 (1999) 364-368
12. Santelli G., Califano D., Chiappetta G., Vento M.T., Bartoli P.C., Zullo F., et al. Thymosin beta-10 gene overexpression is a general event in human carcinogenesis. Am J Pathol 155 (1999) 799-804
13. Cha H.J., Jeong M.J., and Kleinman H.K. Role of thymosin beta4 in tumor metastasis and angiogenesis. J Natl Cancer Inst 95 (2003) 1674-1680
14. Kannan L., Rath N.C., Liyanage R., and Lay Jr. J.O. Identification and characterization of thymosin beta-4 in chicken macrophages using whole cell MALDI-TOF. Ann N Y Acad Sci 1112 (2007) 425-434
15. Kagi D., Ledermann B., Burki K., Seiler P., Odermatt B., Olsen K.J., et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369 (1994) 31-37
16. Biron C.A., Nguyen K.B., Pien G.C., Cousens L.P., and Salazar-Mather T.P. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 17 (1999) 189-220
17. Robertson M.J. Role of chemokines in the biology of natural killer cells. J Leukoc Biol 71 (2002) 173-183
18. Bryceson Y.T., March M.E., Ljunggren H.G., and Long E.O. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 107 (2006) 159-166
19. Marcenaro E., Dondero A., and Moretta A. Multi-directional cross-regulation of NK cell function during innate immune responses. Transpl Immunol 17 (2006) 16-19
20. Vivier E., Tomasello E., Baratin M., Walzer T., and Ugolini S. Functions of natural killer cells. Nat Immunol 9 (2008) 503-510
21. Yoon S.R., Chung J.W., and Choi I. Development of natural killer cells from hematopoietic stem cells. Mol Cells 24 (2007) 1-8
22. Ljunggren H.G., and Malmberg K.J. Prospects for the use of NK cells in immunotherapy of human cancer. Nat Rev Immunol 7 (2007) 329-339
23. Terme M., Ullrich E., Delahaye N.F., Chaput N., and Zitvogel L. Natural killer cell-directed therapies: moving from unexpected results to successful strategies. Nat Immunol 9 (2008) 486-494
24. Alter G., Malenfant J.M., and Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 294 (2004) 15-22
25. Rudin C.M., Engler P., and Storb U. Differential splicing of thymosin beta 4 mRNA. J Immunol 144 (1990) 4857-4862
26. Bauer S., Groh V., Wu J., Steinle A., Phillips J.H., Lanier L.L., et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285 (1999) 727-729
27. Balkow S., Kersten A., Tran T.T., Stehle T., Grosse P., Museteanu C., et al. Concerted action of the FasL/Fas and perforin/granzyme A and B pathways is mandatory for the development of early viral hepatitis but not for recovery from viral infection. J Virol 75 (2001) 8781-8791
28. Nagata S., and Golstein P. The Fas death factor. Science 267 (1995) 1449-1456
29. Robertson M.J., Caligiuri M.A., Manley T.J., Levine H., and Ritz J. Human natural killer cell adhesion molecules Differential expression after activation and participation in cytolysis. J Immunol 145 (1990) 3194-3201
30. Barber D.F., Faure M., and Long E.O. LFA-1 contributes an early signal for NK cell cytotoxicity. J Immunol 173 (2004) 3653-3659
31. Bryceson Y.T., March M.E., Barber D.F., Ljunggren H.G., and Long E.O. Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells. J Exp Med 202 (2005) 1001-1012
32. van Kooyk Y., and Figdor C.G. Avidity regulation of integrins: the driving force in leukocyte adhesion. Curr Opin Cell Biol 12 (2000) 542-547
33. Vyas Y.M., Maniar H., and Dupont B. Visualization of signaling pathways and cortical cytoskeleton in cytolytic and noncytolytic natural killer cell immune synapses. Immunol Rev 189 (2002) 161-178
34. Sosne G., Hafeez S., Greenberry II A.L., and Kurpakus-Wheater M. Thymosin beta4 promotes human conjunctival epithelial cell migration. Curr Eye Res 24 (2002) 268-273
35. Al-Nedawi K.N., Czyz M., Bednarek R., Szemraj J., Swiatkowska M., Cierniewska-Cieslak A., et al. Thymosin beta 4 induces the synthesis of plasminogen activator inhibitor 1 in cultured endothelial cells and increases its extracellular expression. Blood 103 (2004) 1319-1324
36. Yang H., Cheng X., Yao Q., Li J., and Ju G. The promotive effects of thymosin beta4 on neuronal survival and neurite outgrowth by upregulating L1 expression. Neurochem Res 33 (2008) 2269-2280
37. Goldstein A.L., Hannappel E., and Kleinman H.K. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med 11 (2005) 421-429
38. Cierniewski C.S., Malinowski M., Bednarek R., and Cierniewska-Cieslak A. Adhesive and proteolytic phenotype of migrating endothelial cells induced by thymosin beta-4. Ann N Y Acad Sci 1112 (2007) 123-139
39. Cho D.H., Song H.K., Kang H.S., Yoon S.R., Lee H.G., Pyun K.H., et al. Ligation of ICAM-1 molecules inhibits target cell-induced granule exocytosis of IL-12-activated natural killer cells. Cell Immunol 199 (2000) 1-7
40. Orange J.S., Harris K.E., Andzelm M.M., Valter M.M., Geha R.S., and Strominger J.L. The mature activating natural killer cell immunologic synapse is formed in distinct stages. Proc Natl Acad Sci USA 100 (2003) 14151-14156
41. Timonen T., Patarroyo M., and Gahmberg C.G. CD11a-c/CD18 and GP84 (LB-2) adhesion molecules on human large granular lymphocytes and their participation in natural killing. J Immunol 141 (1988) 1041-1046
42. Weller F.E., Mutchnick M.G., Goldstein A.L., and Naylor P.H. Enzyme immunoassay measurement of thymosin beta 4 in human serum. J Biol Response Mod 7 (1988) 91-96
43. Lanier L.L. Evolutionary struggles between NK cells and viruses. Nat Rev Immunol 8 (2008) 259-268
44. Wu J., and Lanier L.L. Natural killer cells and cancer. Adv Cancer Res 90 (2003) 127-156
45. Nakachi K., Hayashi T., Imai K., and Kusunoki Y. Perspectives on cancer immuno-epidemiology. Cancer Sci 95 (2004) 921-929
46. Imai K., Matsuyama S., Miyake S., Suga K., and Nakachi K. Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. Lancet 356 (2000) 1795-1799
47. Ettinghausen S.E., Lipford III E.H., Mule J.J., and Rosenberg S.A. Recombinant interleukin 2 stimulates in vivo proliferation of adoptively transferred lymphokine-activated killer (LAK) cells. J Immunol 135 (1985) 3623-3635
48. Ettinghausen S.E., and Rosenberg S.A. Immunotherapy of murine sarcomas using lymphokine activated killer cells: optimization of the schedule and route of administration of recombinant interleukin-2. Cancer Res 46 (1986) 2784-2792
49. Colombo M.P., and Trinchieri G. Interleukin-12 in anti-tumor immunity and immunotherapy. Cytokine Growth Factor Rev 13 (2002) 155-168
50. Fujii H., Trudeau J.D., Teachey D.T., Fish J.D., Grupp S.A., Schultz K.R., et al. In vivo control of acute lymphoblastic leukemia by immunostimulatory CpG oligonucleotides. Blood 109 (2007) 2008-2013
51. Klinman D.M. Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat Rev Immunol 4 (2004) 249-258